Jeffreys Albright, MD
Orthopaedic Surgery · Gresham, ORNPI 1477533966
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,038 of the $1,638 with a category attached, or 63.4%. Smith+Nephew accounts for 86.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $1,272 and has fallen 87.2% since, to $163 in 2024. That places this record below the midpoint for orthopaedic surgery clinicians in OR, where the typical reported total is $2,454.
Across 16 payments — averaging $102.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$1K
- Vericel Corporation$145
- KCI USA, Inc.$24
- Zimmer Biomet$20
- Merck$18
- Dynasplint Systems Inc.$12
What the payments were for
- Travel & lodging$1,03863%
- Food & beverage$57535%
- Education$241%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 11 | $1,418 |
| Vericel Corporation | 1 | $145 |
| KCI USA, Inc. | 1 | $24 |
| Zimmer Biomet | 1 | $20 |
| Merck | 1 | $18 |
| Dynasplint Systems Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,638 in reported general payments places this provider in the 40th percentile of 228 orthopaedic surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 16 | $4,110 |
| Oxycodone Hcl | 88 | $512 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $209 |
| Hydromorphone Hcl | 13 | $85 |
| Cephalexin | 17 | $30 |
| Amoxicillin | 22 | $16 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Gresham
- Patrick DenardMedford$11.5M
- James BallardOregon City$2.4M
- Steven MadeyLake Oswego$1.2M
- Daniel FitzpatrickEugene$481K
- Michelle WelbornPortland$364K
- Elizabeth LiebermanPortland$353K
- Jonathan SalesPortland$303K
- James HaydenPortland$264K
- Paul DuweliusPortland$144K
- Stefan TarlowPortland$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.